Cymabay Revenue, Profits - CBAY Quarterly Income Statement

Add to My Stocks
$13.2 $0.33 (2.44%) CBAY stock closing price Mar 20, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Cymabay stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the CBAY stock. Revenue for year 2017 Q3 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Cymabay profit and loss statement with those of the prior corresponding period. Also see Cymabay assets and Cymabay free cash flow for a complete valuation of CBAY stock.

View and download details of revenue and profits for Cymabay for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Cymabay Revenues or Net Sales
Cost Of Goods Sold (COGS)---------
Cymabay Gross Profit
Research & Development Expense4.18M4.04M4.04M3.86M3.53M4.13M4.42M4.06M4.52M
Selling General & Admin Expense2.21M3.58M3.7M2.84M2.13M2.21M2.46M1.81M2.2M
Income Before Depreciation Depletion Amortization-6.39M-7.62M-2.94M-6.7M-5.66M-6.34M-6.88M-5.86M-6.72M
Depreciation Depletion Amortization---------
Non Operating Income-1.58M-1.02M-2.09M---0.31M--1.12M
Interest Expense---------
Cymabay Pretax Income
Provision for Income Taxes---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-8.23M-8.93M-5.35M-6.95M-5.88M-6.99M-6.85M-5.98M-5.87M
Extraordinary Items & Discontinued Operations---------
Cymabay Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS40.04M28.75M26.61M23.45M23.45M23.45M23.45M23.45M21.68M
Average Shares used to compute Basic EPS40.04M28.75M26.61M23.45M23.45M23.45M23.45M23.45M21.68M
Income Before Nonrecurring Items-8.23M-8.93M-5.35M-6.95M-5.88M-6.99M-6.85M-5.98M-5.87M
Income from Nonrecurring Items---------
Cymabay Earnings Per Share Basic Net
Cymabay Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.21-0.31-0.20-0.30-0.25-0.30-0.29-0.26-0.27
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Cymabay stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the Cymabay revenue chart, as isn't the case with Cymabay indicates a sagging business. One needs to compare the QoQ topline or sales growth of CBAY stock with its peers like BTCA stock and AMPH stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. CBAY stock had a healthy bottom line growth.

The income statement is also called the profit and loss statement. Apart from the CBAY income statement, one can check the Cymabay historical stock prices to check how the price has moved with time.

Cymabay Income Statement - Key Financial Ratios